SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001144204-13-064519
Filing Date
2013-11-27
Accepted
2013-11-27 13:08:50
Documents
1
Group Members
ANTOINE PAPIERNIKDENIS LUCQUINLUXCAPITAL V S.A R.L.MONIQUE SAULNIERRAFAELE TORDJMANSOFINNOVA CAPITAL V FCPR

Document Format Files

Seq Description Document Type Size
1 SC 13G v361498_sc13g.htm SC 13G 141355
  Complete submission text file 0001144204-13-064519.txt   143014
Mailing Address 2525 28TH STREET SUITE 100 BOULDER CO 80301
Business Address 2525 28TH STREET SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Subject) CIK: 0001466301 (see all company filings)

IRS No.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-86488 | Film No.: 131246772
SIC: 2834 Pharmaceutical Preparations

Mailing Address 17 RUE DE SERENE PARIS I0 75008
Business Address 17 RUE DE SERENE PARIS I0 75008 33 1 53 05 41 13
Sofinnova Partners SAS (Filed by) CIK: 0001574139 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: SC 13G